Innovations and Challenges in Melanoma: Summary Statement from the First Cambridge Conference
Open Access
- 1 April 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 12 (7) , 2291s-2296s
- https://doi.org/10.1158/1078-0432.ccr-05-2560
Abstract
Innovations and Challenges in Melanoma, chaired by Michael Atkins and cochaired by Ulrich Keilholz, John Kirkwood, and Jeffrey Sosman, was held July 15 to 16, 2005, in Cambridge, Massachusetts. The conference brought together leading experts in the fields of cancer research, medical oncology, surgical oncology, anatomic pathology, dermatology, and immunotherapy who wished to advance the field of melanoma treatment by exchanging information and perspectives regarding recent advances and recommendations for further study. The conference proceedings published in this educational supplement to Clinical Cancer Research are intended to provide timely information and recommendations on how genetics, biology, and data information can enhance our understanding of melanoma biology and help inform the use of therapies for this disease.Keywords
This publication has 34 references indexed in Scilit:
- Sentinel Node Biopsy for Early-Stage MelanomaAnnals of Surgery, 2005
- Regulation of immunity by self-reactive T cellsNature, 2005
- Factors Predictive of Tumor-Positive Nonsentinel Lymph Nodes After Tumor-Positive Sentinel Lymph Node Dissection for MelanomaJournal of Clinical Oncology, 2004
- The immunoregulatory role of CD1d-restricted natural killer T cells in diseaseClinical Immunology, 2004
- Lessons learned from the Sunbelt Melanoma TrialJournal of Surgical Oncology, 2004
- Reliability of assessment and circumstances of performance of thorough skin self-examination for the early detection of melanoma in the Check-It-Out ProjectPreventive Medicine, 2004
- Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccineSeminars in Cancer Biology, 2003
- Farnesyl transferase inhibitor SCH66336 is cytostatic, pro‐apoptotic and enhances chemosensitivity to cisplatin in melanoma cellsInternational Journal of Cancer, 2003
- The Role of IL-10 and TGF-β in the Differentiation and Effector Function of T Regulatory CellsInternational Archives of Allergy and Immunology, 2002
- Type 1 T regulatory cellsImmunological Reviews, 2001